GHK-Cu
Also known as Copper peptide, GHK-copper
A copper-binding tripeptide used topically or by injection for skin remodeling, wound healing, and hair support.
Evidence grade C · 6 citations · Last reviewed October 2026
- Regulatory status
- Widely used cosmetically; therapeutic injectable forms are supplied compounded and are not FDA-approved.
- Common routes
- Topical · subcutaneous injection
Overview
GHK-Cu (glycyl-L-histidyl-L-lysine bound to copper ion, Cu²⁺) is a small copper-binding tripeptide found naturally in human plasma, saliva, and urine. Plasma concentrations are highest in young adults — roughly 200 ng/mL at age 20 — and decline substantially with age, a pattern that led researchers to investigate whether restoring GHK-Cu levels could support tissue maintenance. Loren Pickart first isolated the peptide in the 1970s and spent decades characterizing its biology; the bulk of the foundational literature traces directly to his lab.
GHK-Cu is best understood as a cosmeceutical ingredient with a meaningful — though still limited — body of human evidence for topical use. It appears in serums, creams, and wound-care formulations and has been studied in small clinical trials for wrinkle reduction, skin firmness, and photoaged skin. Its role in wound healing and hair follicle support has been explored in laboratory and some clinical settings as well [1] [2].
A separate, less-supported use case involves compounded injectable GHK-Cu for systemic anti-aging effects. This extrapolates from in vitro and animal data; no large-scale human RCTs have been conducted on injectable GHK-Cu, and it is not FDA-approved as a drug. The gap between topical evidence and injectable claims is significant and should be understood before pursuing either form; our full GHK-Cu evidence review treats the two separately.
Where to get GHK-Cu
Every telehealth provider we track that offers GHK-Cu. Partners we work with are shown first.
RxSpan MD
Best for: physician-led, pharmacy-transparent compounded GLP-1 with brand-name options
Editorial score · methodology
ShedRx
Best for: compounded GLP-1 as an injection, drops or lozenges, with lower rates on 6- and 12-month plans
Editorial score · methodology
Live Vital
Best for: low-cost, physician-led compounded GLP-1 with peptide and hormone options
Editorial score · methodology
Eden
Best for: compounded semaglutide or tirzepatide at one flat monthly price that doesn't rise with your dose
Editorial score · methodology
AgelessRx
Best for: longevity-focused GLP-1 care with microdosing and brand-name options
Editorial score · methodology
Bodybuilding Health+
Best for: fitness-brand compounded GLP-1 with hormone and performance programs
Editorial score · methodology
PlexusDx
Best for: nationwide compounded GLP-1 with optional genetic-test personalization
Editorial score · methodology
System Labs
Best for: people seeking peptide and longevity therapies like NAD+, glutathione and sermorelin, plus a MIC+B12 injection
Editorial score · methodology
Pepti
Best for: a low all-in starter price on compounded GLP-1s, with every dose price published up front
Editorial score · methodology
YourHealthRx
Best for: Science-forward GLP-1 and peptide care, flat-rate dosing, built-in follow-up
Editorial score · methodology
PreventiveMD
Best for: flat all-in compounded GLP-1 pricing at every dose, with a choice of named pharmacies
Editorial score · methodology
Editorial score · methodology
Also offered by 23 more providers we track
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money
How it works
GHK-Cu works primarily through copper delivery. Copper is an essential cofactor for enzymes involved in collagen cross-linking (lysyl oxidase), free-radical scavenging (superoxide dismutase), and angiogenesis (VEGF signaling). By chelating Cu²⁺ in a stable but bioavailable complex, GHK transports copper into tissue compartments where it would otherwise be inaccessible [6]. In vitro work in normal human dermal fibroblasts shows that GHK and GHK-Cu stimulate TGF-β secretion, a key upstream driver of collagen and elastin synthesis, and modulate matrix metalloproteinases (MMPs) to support orderly extracellular matrix remodeling [3].
Beyond copper delivery, the GHK peptide backbone itself appears to influence gene expression independently of the copper ion. A 2012 study found that copper-free GHK promoted recovery of epidermal stem cell characteristics in aging skin cells, suggesting the peptide has direct signaling activity [4]. Pickart's bioinformatic analyses of large gene-expression datasets identified GHK as a modulator of hundreds of genes tied to tissue repair and anti-inflammatory pathways, though most of this work is computational and in vitro — not yet confirmed in controlled human trials [2].
What the evidence says
The strongest human evidence for GHK-Cu is in topical cosmetic use. Small clinical studies — most sponsored by cosmetic manufacturers or conducted in academic dermatology settings — have reported improvements in wrinkle depth, skin density, and surface roughness after 8 to 12 weeks of daily application of GHK-Cu-containing formulations. However, most published trials are small (fewer than 30 participants), lack placebo controls, and are not independently replicated. A 2016 preformulation study characterized the physicochemical properties of GHK needed to penetrate the stratum corneum, highlighting that dermal delivery is technically feasible but concentration- and formulation-dependent [5]. Overall, the topical evidence supports a cosmetic benefit signal, but the trial quality does not reach the standard required to make strong therapeutic claims.
GHK-Cu has been studied in wound healing. Animal models consistently show accelerated wound closure, increased collagen deposition, and reduced inflammation with topical GHK-Cu application [1]. Human wound-healing data are limited and largely drawn from small observational reports rather than RCTs. Hair follicle data follow a similar pattern: in vitro and animal studies show GHK-Cu can enlarge follicle size and prolong the anagen (growth) phase, but robust human hair-regrowth trials are lacking. Some dermatologists include copper peptide serums as adjuncts in androgenetic alopecia protocols, though the evidence base for this use is much thinner than for minoxidil or finasteride. The skin and hair trials are examined one at a time in GHK-Cu for skin and hair.
For injectable GHK-Cu, the honest summary is that human clinical evidence is essentially absent. Proponents argue by extrapolation: because GHK-Cu modulates collagen, inflammation, and antioxidant pathways in vitro and in animal models, systemic delivery should amplify those effects. This reasoning is plausible but unproven. No peer-reviewed RCTs of injectable GHK-Cu in humans appear in the biomedical literature. Anyone considering compounded injectable GHK-Cu should understand they are operating well outside the evidence base, and no established safety profile exists for systemic copper peptide administration.
Typical dosing
Topically, GHK-Cu is a cosmetic ingredient, and the concentration in a serum or cream is set by the manufacturer; a concentration is not a dose and cannot be converted into one. We have not verified a published range we would present as a standard, so we do not quote one. Stability is a practical concern: GHK-Cu degrades in high-pH or highly oxidizing formulations, so formulation quality matters.
For injectable use, there is no human pharmacokinetic study, no established effective dose, no validated treatment duration, and no standard monitoring protocol. The milligram doses quoted by some providers are not taken from human studies, so we do not repeat them. Anyone pursuing injectable use should treat it as experimental, and the GHK-Cu dosage evidence page records what regulators have and have not published.
Safety & side effects
Topical GHK-Cu is generally well-tolerated in the concentrations found in cosmeceuticals. The most commonly reported adverse effects are mild and transient: skin irritation, redness, or a transient blue-green tint on skin from the copper complex. Copper itself is an essential nutrient at low doses, and dermal absorption from topical application is minimal, so systemic copper accumulation from a serum or cream is not a meaningful concern for most users.
Injectable GHK-Cu carries a different risk profile. Copper toxicity — manifesting as nausea, liver injury, and neurological effects — is a documented consequence of systemic copper overload. Whether therapeutic dosing of compounded injectable GHK-Cu can reach toxic thresholds has not been formally studied. The injectable form is not FDA-approved, is not subject to pharmaceutical manufacturing quality controls, and lacks a characterized safety profile in humans. People with Wilson’s disease or other copper-metabolism disorders should avoid all GHK-Cu formulations. As with any compounded injectable peptide, injection-site infections and sterility risks are relevant.
Frequently asked questions
Does GHK-Cu regrow hair?
The evidence is suggestive but not conclusive. Laboratory studies show that GHK-Cu can enlarge hair follicles and extend the growth phase in cell and animal models, and some small clinical observations support a modest hair-thickening effect. However, no large, well-controlled human RCT has established GHK-Cu as an effective hair-regrowth treatment. It is sometimes used as an adjunct in cosmetic hair protocols, but its effect size compared with established options like minoxidil is unknown.
Is GHK-Cu safe to inject?
There is no established safety profile for injectable GHK-Cu in humans. The compound is not FDA-approved for injection, and no clinical trials have characterized its pharmacokinetics, effective dose range, or adverse-event profile when given subcutaneously. Copper toxicity is a real concern with systemic copper exposure, and compounded injectable preparations lack the quality-control safeguards of pharmaceutical manufacturing. Injectable GHK-Cu should be considered experimental.
What GHK-Cu concentration should I look for in a serum?
There is no validated concentration standard, and the small cosmetic trials used their own formulations, so we do not recommend a number. Formulation stability matters as much as concentration: GHK-Cu degrades in high-pH or strongly oxidizing products, so look for a reputable manufacturer and packaging that limits light and air.
How long does topical GHK-Cu take to work?
The small clinical trials that exist report measurable changes in wrinkle depth and skin texture after 8 to 12 weeks of consistent use. Individual results vary considerably depending on baseline skin condition, formulation quality, and application consistency. GHK-Cu is not a rapid-acting ingredient; it works through gradual changes in collagen remodeling rather than surface-level effects.
Is GHK-Cu FDA-approved?
As a cosmetic ingredient, GHK-Cu does not require FDA approval and is freely used in over-the-counter serums and creams. As a therapeutic drug — whether injected or applied with specific medical claims — it is not FDA-approved. Compounded injectable GHK-Cu exists in a regulatory gray area: it is prepared by licensed compounding pharmacies but has not undergone the clinical-trial process required for FDA drug approval.
Can GHK-Cu be stacked with other peptides or skincare actives?
Topically, GHK-Cu is commonly combined with retinoids, vitamin C, or other peptides in cosmeceutical routines. However, it should not be mixed in the same application with ascorbic acid at high concentrations, as the oxidizing environment can degrade the copper complex. Layering as separate steps is preferable. For injectable stacking, there is no human data on combination protocols; any such use is experimental and should be approached with caution.
Sources
- [1] Pickart L The Human Tri-peptide GHK and Tissue Remodeling Journal of Biomaterials Science. Polymer Edition (2008). PMID 18644225
- [2] Pickart L, Vasquez-Soltero JM, Margolina A GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration BioMed Research International (2015). PMID 26236730
- [3] Gruchlik A, Chodurek E, Dzierzewicz Z Effect of GLY-HIS-LYS and its copper complex on TGF-β secretion in normal human dermal fibroblasts Acta Poloniae Pharmaceutica (2014). PMID 25745767
- [4] Choi HR, Kang YA, Ryoo SJ, Shin JW, Na JI, Huh CH, Park KC Stem cell recovering effect of copper-free GHK in skin Journal of Peptide Science (2012). PMID 23019153
- [5] Badenhorst T, Svirskis D, Wu Z Physicochemical characterization of native glycyl-l-histidyl-l-lysine tripeptide for wound healing and anti-aging: a preformulation study for dermal delivery Pharmaceutical Development and Technology (2016). PMID 25384620
- [6] Bossak-Ahmad K, Wiśniewska MD, Bal W, Drew SC, Frączyk T Ternary Cu(II) Complex with GHK Peptide and Cis-Urocanic Acid as a Potential Physiologically Functional Copper Chelate International Journal of Molecular Sciences (2020). PMID 32867146
Further reading
- GHK-Cu: the full evidence review The copper peptide research in detail.
- GHK-Cu for skin and hair Whether the copper peptide works for skin and hair.
- KLOW blends that include GHK-Cu GHK-Cu is not on the HHS Appendix A list, so these blends fall outside the policy.
- All peptides we cover Evidence grades and regulatory status side by side.
Related peptides
Browse the full peptide directory, see what GLP-1s treat by condition, or compare the best GLP-1 providers.
Educational information only — not medical advice.